Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-10-21 23:17 | 2014-10-17 | RDEN | N/A | Rhone Capital L.L.C. | 10% owner | Other | BUY | $16.99 | 559,684 | $9,507,128 | 3,834,122 | +17.1% |
| 2014-10-21 20:32 | 2014-10-20 | N/A | N/A | State of Connecticut Retirement Plans & Trust Funds | 10% owner | Other | BUY | $19.96 | 170,796 | $3,409,088 | 1,262,684 | +15.6% |
| 2014-10-22 00:15 | 2014-10-17 | GNK | GENCO SHIPPING & TRADING LTD | Strategic Value Partners, LLC | 10% owner | Deep Sea Foreign Transportation of Freight | BUY | $14.50 | 100,000 | $1,450,000 | 1,868,917 | +5.7% |
| 2014-10-22 00:48 | 2014-10-20 | SHLD | N/A | BERKOWITZ BRUCE R | 10% owner | Other | BUY | $32.75 | 144,500 | $4,731,653 | 24,838,773 | +0.6% |
| 2014-10-22 01:53 | 2014-10-21 | ESPR | Esperion Therapeutics, Inc. | JANNEY DANIEL | Director, 10% owner | Pharmaceutical Preparations | BUY | $20.00 | 500,000 | $10,000,000 | 2,552,189 | +24.4% |
| 2014-10-22 02:33 | 2014-10-21 | ESPR | Esperion Therapeutics, Inc. | Alta Partners VIII, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $20.00 | 500,000 | $10,000,000 | 2,552,189 | +24.4% |
| 2014-10-21 19:15 | 2014-10-21 | ESPR | Esperion Therapeutics, Inc. | DOMAIN PARTERS VII L P | 10% owner | Pharmaceutical Preparations | BUY | $20.00 | 500,000 | $10,000,000 | 2,566,935 | +24.2% |
| 2014-10-21 17:34 | 2014-10-21 | ATRA | Atara Biotherapeutics, Inc. | Domain Partners VIII, L.P. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $11.00 | 248,159 | $2,729,749 | 2,141,542 | +13.1% |
| 2014-10-21 00:09 | 2014-10-17 | ACGO | AGCO Corporation | SRINIVASAN MALLIKA | Director, 10% owner | Farm Machinery & Equipment | BUY | $43.95 | 180,000 | $7,911,144 | 8,036,393 | +2.3% |
| 2014-10-21 00:45 | 2014-10-16 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $335.35 | 122,127 | $40,955,057 | 22,657,685 | +0.5% |
| 2014-10-17 20:32 | 2014-10-15 | USDP | USD Partners LP | SANDERS BRADFORD TIMOTHY | Director, Other | Railroad Switching & Terminal Establishments | BUY | $17.00 | 125,000 | $2,125,000 | 125,000 | +100.0% |
| 2014-10-18 00:11 | 2014-10-16 | ACGO | AGCO Corporation | SRINIVASAN MALLIKA | Director, 10% owner | Farm Machinery & Equipment | BUY | $45.08 | 104,379 | $4,704,988 | 7,856,393 | +1.3% |
| 2014-10-18 01:31 | 2014-10-15 | ALSN | Allison Transmission Holdings Inc. | ValueAct Holdings, L.P. | 10% owner, Other | Motor Vehicle Parts & Accessories | BUY | $26.76 | 100,000 | $2,675,750 | 19,125,204 | +0.5% |
| 2014-10-18 00:05 | 2014-10-15 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $328.16 | 158,368 | $51,970,265 | 22,535,558 | +0.7% |
| 2014-10-17 00:12 | 2014-10-15 | AGCO | AGCO Corporation | SRINIVASAN MALLIKA | Director, 10% owner | Farm Machinery & Equipment | BUY | $44.12 | 104,795 | $4,623,210 | 7,752,014 | +1.4% |
| 2014-10-15 23:24 | 2014-10-10 | BAMM | N/A | ANDERSON CLYDE B | Director, Officer, 10% owner, Other - Executive Chairman | Other | BUY | $1.56 | 1,059,662 | $1,653,073 | 3,117,246 | +51.5% |
| 2014-10-16 00:19 | 2014-10-14 | AGCO | AGCO Corporation | SRINIVASAN MALLIKA | Director, 10% owner | Farm Machinery & Equipment | BUY | $43.78 | 114,269 | $5,002,731 | 7,647,219 | +1.5% |
| 2014-10-16 02:51 | 2014-10-13 | CALA | Calithera Biosciences Inc. | ADAGE CAPITAL PARTNERS GP LLC | 10% owner | Pharmaceutical Preparations | BUY | $6.96 | 181,700 | $1,264,577 | 2,765,675 | +7.0% |
| 2014-10-16 04:55 | 2014-10-13 | ENTG | ENTEGRIS INC | GMT CAPITAL CORP | 10% owner | Plastics Products, NEC | BUY | $10.98 | 164,700 | $1,808,406 | 14,468,100 | +1.2% |
| 2014-10-16 04:44 | 2014-10-06 | ENTG | ENTEGRIS INC | GMT CAPITAL CORP | 10% owner | Plastics Products, NEC | BUY | $11.66 | 148,300 | $1,729,178 | 14,298,400 | +1.0% |
| 2014-10-15 00:05 | 2014-10-13 | AGCO | AGCO Corporation | SRINIVASAN MALLIKA | Director, 10% owner | Farm Machinery & Equipment | BUY | $42.84 | 100,000 | $4,284,000 | 7,532,950 | +1.3% |
| 2014-10-15 00:02 | 2014-10-10 | AGCO | AGCO Corporation | SRINIVASAN MALLIKA | Director, 10% owner | Farm Machinery & Equipment | BUY | $42.38 | 112,459 | $4,766,012 | 7,432,950 | +1.5% |
| 2014-10-15 00:46 | 2014-10-10 | RDEN | N/A | Rhone Capital L.L.C. | 10% owner | Other | BUY | $17.00 | 120,912 | $2,055,456 | 3,174,419 | +4.0% |
| 2014-10-15 00:16 | 2014-10-10 | ALSN | Allison Transmission Holdings Inc. | ValueAct Holdings, L.P. | 10% owner, Other | Motor Vehicle Parts & Accessories | BUY | $27.33 | 200,000 | $5,466,760 | 19,050,204 | +1.1% |
| 2014-10-15 00:15 | 2014-10-09 | ETE | Energy Transfer LP | WARREN KELCY L | Director, 10% owner | Natural Gas Transmission | BUY | $51.22 | 1,200,000 | $61,468,680 | 39,551,100 | +3.1% |
| 2014-10-15 01:12 | 2014-10-09 | AAMC | N/A | Luxor Capital Group, LP | 10% owner | Other | BUY | $644.68 | 22,842 | $14,725,847 | 50,732 | +81.9% |
| 2014-10-15 00:08 | 2014-10-13 | SHLD | N/A | BERKOWITZ BRUCE R | 10% owner | Other | BUY | $25.31 | 50,000 | $1,265,500 | 24,694,273 | +0.2% |
| 2014-10-15 01:54 | 2007-06-20 | MEAS | N/A | TOPFER MORTON L | Director | Other | BUY | $21.97 | 60,076 | $1,319,996 | 813,068 | +8.0% |
| 2014-10-15 00:19 | 2014-10-09 | SABA | N/A | Emancipation Management LLC | 10% owner | Other | BUY | $13.36 | 159,100 | $2,125,194 | 3,325,470 | +5.0% |
| 2014-10-15 00:29 | 2014-10-10 | WAG | N/A | Rosenstein Barry | Director | Other | BUY | $61.86 | 1,250,000 | $77,329,000 | 13,750,000 | +10.0% |
| 2014-10-11 00:07 | 2014-10-09 | AGCO | AGCO Corporation | SRINIVASAN MALLIKA | Director, 10% owner | Farm Machinery & Equipment | BUY | $42.44 | 108,472 | $4,603,552 | 7,320,491 | +1.5% |
| 2014-10-10 22:55 | 2014-04-29 | GMEC | N/A | Kwong Kwan Yin Roy | Director, Officer, 10% owner - CEO, CFO | Other | BUY | $0.40 | 9,000,000 | $3,600,000 | 10,305,932 | +689.2% |
| 2014-10-10 20:16 | 2014-10-08 | GTIM | Good Times Restaurants Inc. | STETSON ROBERT J | Director, 10% owner | Retail-Eating Places | BUY | $4.10 | 300,000 | $1,230,000 | 880,000 | +51.7% |
| 2014-10-10 19:07 | 2014-10-10 | NRP | NATURAL RESOURCE PARTNERS LP | ROBERTSON CORBIN J JR | Director, Officer, 10% owner - Chairman and CEO | Bituminous Coal & Lignite Surface Mining | BUY | $12.02 | 270,383 | $3,250,004 | 52,339 | +100.0% |
| 2014-10-11 00:19 | 2014-10-09 | TYG | TORTOISE ENERGY INFRASTRUCTURE CORP | Athene Holding Ltd | 10% owner | Other | BUY | $10.00 | 760,000 | $7,600,000 | 280,000 | +100.0% |
| 2014-10-09 16:47 | 2014-10-07 | AAC | N/A | Bostelman Jerry D. | Director | Other | BUY | $15.00 | 84,523 | $1,267,845 | 673,644 | +14.3% |
| 2014-10-09 23:34 | 2014-10-08 | ECC | Eagle Point Credit Co Inc. | Eagle Point Credit Management LLC | Other | Other | BUY | $20.00 | 100,000 | $2,000,000 | 100,000 | +100.0% |
| 2014-10-10 00:03 | 2014-10-08 | AGCO | AGCO Corporation | SRINIVASAN MALLIKA | Director, 10% owner | Farm Machinery & Equipment | BUY | $42.31 | 127,042 | $5,375,325 | 7,212,019 | +1.8% |
| 2014-10-10 02:26 | 2014-10-07 | RDEN | N/A | Rhone Capital L.L.C. | 10% owner | Other | BUY | $16.96 | 149,443 | $2,534,987 | 3,053,507 | +5.1% |
| 2014-10-09 23:43 | 2014-10-07 | CALA | Calithera Biosciences Inc. | MORGENTHALER VENTURE PARTNERS IX LP | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 350,000 | $3,500,000 | 2,161,915 | +19.3% |
| 2014-10-09 23:45 | 2014-10-07 | CALA | Calithera Biosciences Inc. | Advanced Technology Ventures VIII LP | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 300,000 | $3,000,000 | 2,110,082 | +16.6% |
| 2014-10-09 23:49 | 2014-10-07 | ALSN | Allison Transmission Holdings Inc. | ValueAct Holdings, L.P. | 10% owner, Other | Motor Vehicle Parts & Accessories | BUY | $27.75 | 275,000 | $7,631,003 | 18,850,204 | +1.5% |
| 2014-10-09 16:46 | 2014-10-06 | AAMC | N/A | Luxor Capital Group, LP | 10% owner | Other | BUY | $673.22 | 2,472 | $1,664,195 | 27,890 | +9.7% |
| 2014-10-09 23:41 | 2014-10-07 | CALA | Calithera Biosciences Inc. | Christoffersen Ralph E | Director, 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 350,000 | $3,500,000 | 2,161,915 | +19.3% |
| 2014-10-09 23:40 | 2014-10-07 | CALA | Calithera Biosciences Inc. | George Jean | Director, 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 300,000 | $3,000,000 | 2,110,082 | +16.6% |
| 2014-10-10 04:02 | 2014-10-08 | VTL | IMMUNIC, INC. | Satter Muneer A | Director, 10% owner | Pharmaceutical Preparations | BUY | $17.50 | 74,286 | $1,300,005 | 6,732,277 | +1.1% |
| 2014-10-09 23:49 | 2014-10-07 | CALA | Calithera Biosciences Inc. | PAKIANATHAN DEEPIKA | Director, 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 500,000 | $5,000,000 | 23,464 | +100.0% |
| 2014-10-10 03:44 | 2014-10-07 | CALA | Calithera Biosciences Inc. | Delphi Management Partners VIII, L.L.C. | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 500,000 | $5,000,000 | 23,464 | +100.0% |
| 2014-10-10 02:08 | 2014-10-01 | WWWW | N/A | Okumus Fund Management Ltd. | 10% owner | Other | BUY | $18.88 | 407,376 | $7,692,277 | 7,302,555 | +5.9% |
| 2014-10-08 16:13 | 2014-10-06 | DVLY | N/A | PEERLESS SYSTEMS CORP | 10% owner | Other | BUY | $0.29 | 12,436,458 | $3,651,344 | 12,436,458 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.